达尔皮西克利布加上芳酶抑制剂与ER阳性,HER2阴性乳腺癌的新辅助化疗相比

Haoqi Wang1,2, Guoyu Zhang3, Wei Gao1

  • 1Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

PubMed
概括

达尔皮西克利布加上芳酶抑制剂对激素受体阳性乳腺癌的新辅助化疗具有类似的疗效,但具有更好的安全性. 这种组合疗法显示出作为替代治疗选择的希望.

相关概念视频

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...